Hapharcoj S Cbranch Pharmaceutical Import Profile — Vietnam (DGFT 2022–2026)

Name: Hapharcoj S Cbranch Pharmaceutical Import Records from India — 3 Products, $450.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Hapharcoj S Cbranch — Pharmaceutical Importer Profile (2026) | 3 Products, $450.0K Trade | TransData Nexus

Hapharcoj S Cbranch

Pharmaceutical Importer · Vietnam · Antimalarial & Antiparasitic Focus · $450.0K Total Trade · DGFT Verified

Hapharcoj S Cbranch is a pharmaceutical importer based in Vietnam with a total trade value of $450.0K across 3 products in 2 therapeutic categories. Based on 9 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Hapharcoj S Cbranch sources from 3 verified Indian suppliers, with Sun Pharmaceutical Industries Limited accounting for 53.9% of imports.

Hapharcoj S Cbranch — Import Portfolio & Supplier Network

Hapharcoj S Cbranch import network — 3 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Hapharcoj S Cbranch?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Sun Pharmaceutical Industries Limited	$820.8K	28	53.9%
Cadila Healthcare Limited	$687.6K	33	45.1%
Windlas Biotech Private Limited	$15.0K

What Formulations Does Hapharcoj S Cbranch Import?

Formulation	Value	Ships
Chemodox 2MG/ML 10ML injection doxorubicin hydrochloride liposome injection 2MG/ML 10ML vial [Pack: 1	$150.0K	3
Hcq hydroxychloroquine sulphate USP 200MG 10 x	$100.0K	2
Sunmedabon TAB 200/0.2MG 5x1s vn pack5s strip sap code : 1148169 hsn code	$75.6K	2
Forair 250 salmeterol & fluticasone propionate inhalation inhaler 1x120	$73.2K	3
Sap code : 1136148 hsn code : 30049099 sun sizopin 25 tablets clozapine	$64.5K	2
Chemodox 2MG/ML, 10ML injection doxorubin hydrochloride liposome injection 2MG/ML, 10ML vial [Pack: 1	$50.0K	1
Chemodox 2MG/ML, 10ML injection doxorubicin hydrochloride liposome injection 2MG/ML, 10ML vial [Pack: 1	$50.0K	1
Formonide 200 inhalerbudesonide & formoterol fumarate	$50.0K	1
Noklot 75MG 3x10 tabletsclopidogrel3x10	$50.0K	1
Vertiko 24MG tablets betahistine dihydrochloride tablets BP 24MG	$50.0K	1
Hcq hydrochloroquine sulphate USP 200MG 10 x	$50.0K	1
Encorate tabs sodium valproate entericcoated tablets BP 200MG	$50.0K	1
Defothal TAB 500MG defrasirox tablets500 MG sap code : 1152773 batch : pte4059a mfd : 29.09.2023 exp	$50.0K	1
Pantocid i.v. injectionspantoprazole Pack	$49.0K	1
Valazyd 160MG valasartan	$45.8K	1

Hapharcoj S Cbranch imports 54 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 3 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Doxorubicin	Oncology	$200.0K	4	0.3%	13
2	Chloroquine	Antimalarial & Antiparasitic	$150.0K	3	0.1%	12
3	Hydroxychloroquine	Antimalarial & Antiparasitic	$100.0K	2	0.1%	12

Hapharcoj S Cbranch imports 3 pharmaceutical products across 2 categories into Vietnam totaling $450.0K.

Hapharcoj S Cbranch — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Hapharco J.S.C. Branch, operating in Ho Chi Minh City, Vietnam, is a pharmaceutical importer specializing in the acquisition of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. The company plays a pivotal role in Vietnam's pharmaceutical distribution network, ensuring the availability of essential medications to meet the country's healthcare demands. While specific details about its parent company are not publicly disclosed, Hapharco J.S.C. Branch is recognized for its substantial import activities, particularly from India, Russia, and Pakistan.

2Distribution Network

Hapharco J.S.C. Branch's distribution network is strategically located in Ho Chi Minh City, a central hub for pharmaceutical logistics in Vietnam. The company operates a distribution center that adheres to Good Storage Practices (GSP), ensuring the integrity and quality of imported pharmaceutical products. This facility is equipped to handle a diverse range of pharmaceutical products, facilitating efficient storage and distribution across Vietnam. (gmp.com.vn)

3Industry Role

Within Vietnam's pharmaceutical supply chain, Hapharco J.S.C. Branch functions primarily as a wholesaler and distributor. By importing a variety of finished pharmaceutical formulations, the company bridges the gap between international manufacturers and the Vietnamese market, ensuring that healthcare providers have access to a wide array of medications. This role is crucial in maintaining the flow of essential drugs throughout the country.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Hapharcoj S Cbranch

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Hapharco J.S.C. Branch demonstrates a high degree of sourcing concentration, with a significant portion of its imports originating from India. This strategic choice allows the company to leverage India's robust pharmaceutical manufacturing capabilities and competitive pricing. The shipment data indicates a stable relationship with key suppliers, such as Sun Pharmaceutical Industries Ltd and Cadila Healthcare Ltd, suggesting a reliable and consistent supply chain.

2Supply Chain Resilience

The resilience of Hapharco J.S.C. Branch's supply chain is bolstered by its diversified supplier base, encompassing manufacturers from India, Russia, and Pakistan. This diversification mitigates risks associated with over-reliance on a single source. The company's adherence to Good Storage Practices (GSP) standards further enhances supply chain reliability by ensuring the quality and safety of imported pharmaceutical products. (gmp.com.vn)

3Strategic Implications

Hapharco J.S.C. Branch's sourcing pattern positions it competitively within Vietnam's pharmaceutical market. By maintaining strong relationships with reputable suppliers, the company ensures a steady supply of high-quality medications. For Indian exporters, this presents an opportunity to strengthen partnerships with Hapharco J.S.C. Branch, potentially expanding their market presence in Vietnam through a well-established distribution channel.

Importing Pharmaceuticals into Vietnam — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Vietnam

1Regulatory Authority & Framework

In Vietnam, the Drug Administration of Vietnam (DAV) is the primary regulatory body overseeing pharmaceutical imports. The importation of pharmaceutical products is governed by the Law on Pharmacy No. 105/2016/QH13, which outlines the requirements for drug registration, import licensing, and distribution. Decree No. 54/2017/ND-CP provides detailed provisions for implementing the Law on Pharmacy, specifying conditions for obtaining import licenses and ensuring the safety and efficacy of imported drugs. (hmlf.vn)

2Import Licensing & GMP

To import pharmaceutical products into Vietnam, companies must obtain an import license issued by the Ministry of Health. This license is contingent upon possessing a Certificate of Eligibility for Pharmaceutical Business and complying with Good Storage Practices (GSP) standards. Additionally, imported drugs must be registered with the DAV and granted Market Authorization, ensuring they meet the necessary quality and safety standards. (hmlf.vn)

3Quality & Labeling

Hapharcoj S Cbranch — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Hapharco J.S.C. Branch's focus on importing antimalarial, antiparasitic, and oncology drugs aligns with Vietnam's healthcare priorities. The prevalence of malaria and other parasitic diseases in certain regions of Vietnam drives the demand for antimalarial and antiparasitic medications. Additionally, the rising incidence of cancer in the country necessitates a steady supply of oncology drugs to meet patient needs.

2Sourcing Profile

Hapharco J.S.C. Branch's sourcing strategy emphasizes the procurement of generic drugs, particularly in the antimalarial, antiparasitic, and oncology categories. The company imports a diverse range of formulations, including tablets, capsules, syrups, and injections, to cater to various patient needs. India's established pharmaceutical manufacturing sector plays a significant role in fulfilling these procurement requirements.

3Market Positioning

By importing a comprehensive portfolio of antimalarial, antiparasitic, and oncology drugs, Hapharco J.S.C. Branch serves a broad segment of the Vietnamese market. The company's products are distributed to retail pharmacies, hospitals, and government healthcare facilities, ensuring that essential medications are accessible to a wide range of patients across the country.

Seller's Guide — How to Become a Supplier to Hapharcoj S Cbranch

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a viable opportunity for new Indian suppliers to collaborate with Hapharco J.S.C. Branch, especially in the oncology and antimalarial sectors. The company's established distribution network and focus on high-demand therapeutic areas present a promising avenue for expanding market reach in Vietnam. Potential gaps in Hapharco J.S.C. Branch's current sourcing include the need for additional suppliers to diversify its product offerings and mitigate supply chain risks.

2Requirements & Qualifications

Indian exporters aiming to supply Hapharco J.S.C. Branch must ensure that their products are registered with the Drug Administration of Vietnam and possess Market Authorization. Compliance with Good Manufacturing Practice (GMP) standards is mandatory, and products must meet Vietnamese labeling requirements, including the provision of usage instructions in Vietnamese. Additionally, adherence to serialization mandates is essential to facilitate traceability and ensure product authenticity.

3How to Approach

Frequently Asked Questions — Hapharcoj S Cbranch

What products does Hapharcoj S Cbranch import from India?

Hapharcoj S Cbranch imports 3 pharmaceutical products across 2 categories. Top imports: Doxorubicin ($200.0K), Chloroquine ($150.0K), Hydroxychloroquine ($100.0K).

Who supplies pharmaceuticals to Hapharcoj S Cbranch from India?

Hapharcoj S Cbranch sources from 3 verified Indian suppliers. The primary supplier is Sun Pharmaceutical Industries Limited (53.9% of imports, $820.8K).

What is Hapharcoj S Cbranch's total pharmaceutical import value?

Hapharcoj S Cbranch's total pharmaceutical import value from India is $450.0K, based on 9 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Hapharcoj S Cbranch focus on?

Hapharcoj S Cbranch imports across 2 categories. The largest: Antimalarial & Antiparasitic (55.6%), Oncology (44.4%).

Get Full Hapharcoj S Cbranch Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.